• Publications
  • Influence
[Interferon therapy of multiple sclerosis].
  • D. Jensen
  • Medicine
  • Tidsskrift for den Norske laegeforening…
  • 10 September 1999
The use of beta-interferon in the relapsing-remitting phase of multiple sclerosis is a new though fairly established therapy. The beneficial effect of this treatment is thought to be due to immuneExpand
[Optic neuritis--diagnosis, treatment and follow up].
A national group of neurologists and ophthalmologists have evaluated guidelines and recommendations for diagnosis, treatment and follow up of optic neuritis based on clinical experience and a reviewExpand
[Retraction of article].
[Cetiprin 'Kabi' (emepronium bromide). A new anticholinergic agent with selective action on the urinary bladder].
  • D. Jensen
  • Medicine
  • Tidsskrift for den Norske laegeforening…
  • 10 October 1974
[Electromyography of the anal sphincter].
  • D. Jensen
  • Medicine
  • Tidsskrift for den Norske laegeforening…
  • 20 April 1980
[Editorial: Lisidonil (hydramitrazine) in treatment of unchecked neurogenic urinary bladder].
  • D. Jensen
  • Medicine
  • Tidsskrift for den Norske laegeforening…
  • 30 November 1975
[Plastic bag appliance with colostomy].
  • D. Jensen
  • Medicine
  • Tidsskrift for den Norske laegeforening…
  • 1957
[New diagnostic criteria in multiple sclerosis].
[Charcot-Marie-Tooth disease. Peroneal muscular atrophy].
The classification of Charcot-Marie-Tooth disease is provisional, because the chromosome and gene localization is still not precisely known, and gene products have not been identified. This articleExpand
[Risks for iatrogenic urinary infection following cystometry].
  • D. Jensen
  • Medicine
  • Tidsskrift for den Norske laegeforening…
  • 30 May 1975
...
1
2
...